Sarcopenia and Fat Mass in Children With Chronic Liver Disease and Its Impact on Liver Transplantation

Eirini Kyrana1, Jane E Williams2, Jonathan C Wells2

  • 1From the King's College Hospital NHS Foundation Trust and MowatLabs, London, United Kingdom.

JPGN Reports
|May 11, 2023
PubMed

Insights

Sarcopenia, or low muscle mass, in children awaiting liver transplants (LT) did not predict outcomes one year post-transplant. However, body composition did influence hospital discharge times after LT.

Area of Science:

  • Pediatric Hepatology
  • Transplant Surgery
  • Nutritional Science

Background:

  • Sarcopenia and weight loss are poor prognostic indicators in adult liver transplant (LT) candidates.
  • The prognostic value of sarcopenia in pediatric LT candidates remains unclear.

Purpose of the Study:

  • To investigate the relationship between sarcopenia and outcomes in children awaiting LT.
  • To assess the impact of body composition on post-LT recovery.

Main Methods:

  • An observational longitudinal study included children with end-stage chronic liver disease assessed for LT.
  • Body composition (BC) was measured using dual-energy x-ray absorptiometry before and one year after LT.
  • Anthropometric data and clinical outcomes were recorded.

Main Results:

  • Four of eleven pediatric LT candidates were sarcopenic at baseline (appendicular lean mass index SD score < -1.96).
  • Fat mass index correlated negatively with height, but was otherwise normal.
  • Post-LT, trunk lean mass index significantly decreased, and low body mass index correlated with longer hospital discharge times.
  • All patients survived one year post-LT with normal graft function, irrespective of baseline body composition.

Conclusions:

  • Sarcopenia in children awaiting LT was not associated with poor outcomes one year after transplant.
  • Body composition influenced post-transplant hospital discharge duration but not long-term graft function or survival.